Author:
Brower J.V.,Amini A.,Chen S.,Hullett C.R.,Kimple R.J.,Wojcieszynski A.P.,Bassetti M.,Witek M.E.,Yu M.,Harari P.M.,Baschnagel A.M.
Reference29 articles.
1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015
2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008
3. Non-small cell lung cancer survival rates, by stage,2014
4. J Natl Cancer Inst;Curran;Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410,2011
5. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study